Quest Diagnostics Set to Announce Q1 Earnings with Strong Estimates
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 21 hours ago
0mins
Should l Buy DGX?
Source: seekingalpha
- Earnings Announcement Date: Quest Diagnostics is set to release its Q1 earnings on April 21 before market open, with consensus EPS estimated at $2.37, reflecting a 7.2% year-over-year increase, which indicates sustained profitability and could boost investor confidence.
- Revenue Growth Expectations: The anticipated Q1 revenue of $2.83 billion represents a 6.8% year-over-year growth, highlighting strong demand in the medical testing sector and potentially laying the groundwork for future business expansion.
- Historical Performance: Over the past two years, Quest Diagnostics has beaten both EPS and revenue estimates 100% of the time, showcasing its financial robustness and market adaptability, which enhances investor confidence in its future performance.
- Estimate Revision Dynamics: In the last three months, EPS estimates have seen 5 upward revisions and 6 downward adjustments, while revenue estimates experienced 9 upward revisions with no downward changes, indicating analysts' optimistic outlook on the company's future performance, likely attracting more investor interest.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy DGX?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on DGX
Wall Street analysts forecast DGX stock price to rise
5 Analyst Rating
3 Buy
2 Hold
0 Sell
Moderate Buy
Current: 195.020
Low
190.00
Averages
203.33
High
210.00
Current: 195.020
Low
190.00
Averages
203.33
High
210.00
About DGX
Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company provides diagnostic insights from the results of its laboratory testing to enable people, physicians, and organizations to take action to improve health outcomes. It operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. It offers broad access to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. It also focuses on artificial intelligence (AI) and digital pathology solutions. The Company’s services primarily are provided under the Quest Diagnostics brand and under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Quest Diagnostics Set to Announce Q1 Earnings with Strong Estimates
- Earnings Announcement Date: Quest Diagnostics is set to release its Q1 earnings on April 21 before market open, with consensus EPS estimated at $2.37, reflecting a 7.2% year-over-year increase, which indicates sustained profitability and could boost investor confidence.
- Revenue Growth Expectations: The anticipated Q1 revenue of $2.83 billion represents a 6.8% year-over-year growth, highlighting strong demand in the medical testing sector and potentially laying the groundwork for future business expansion.
- Historical Performance: Over the past two years, Quest Diagnostics has beaten both EPS and revenue estimates 100% of the time, showcasing its financial robustness and market adaptability, which enhances investor confidence in its future performance.
- Estimate Revision Dynamics: In the last three months, EPS estimates have seen 5 upward revisions and 6 downward adjustments, while revenue estimates experienced 9 upward revisions with no downward changes, indicating analysts' optimistic outlook on the company's future performance, likely attracting more investor interest.
See More
Quest Diagnostics Q1 Earnings Exceed Expectations
- Earnings Beat: Quest Diagnostics reported a Q1 non-GAAP EPS of $2.50, exceeding expectations by $0.13, which reflects the company's strong performance and boosts investor confidence.
- Significant Revenue Growth: The company achieved revenues of $2.89 billion in Q1, marking a 9.1% year-over-year increase and surpassing market expectations by $60 million, indicating sustained business growth and effective market demand response.
- 2026 Guidance Update: The company raised its 2026 fiscal year net revenue guidance to between $11.78 billion and $11.90 billion, up from the previous range of $11.70 billion to $11.82 billion, reflecting an optimistic outlook for future performance.
- Stable Cash Flow: Expected operating cash flow is approximately $1.75 billion with capital expenditures around $550 million, demonstrating the company's solid financial health and investment capacity.
See More
Quest Diagnostics Reports Over 9% Revenue Growth in Q1
- Significant Revenue Growth: Quest Diagnostics reported net revenues of $2.895 billion for Q1, reflecting a 9.2% year-over-year increase, almost entirely driven by organic growth, showcasing the company's strategic execution in delivering innovative diagnostic solutions.
- Earnings Per Share Increase: The adjusted diluted EPS rose by 15.5% to $2.50, indicating successful operational efficiency and cost control, which further bolsters investor confidence in the company's financial health.
- Upgraded Full-Year Guidance: Following a robust first quarter, the company raised its 2026 revenue guidance to between $11.78 billion and $11.90 billion, with expected growth rates of 6.8% to 7.8%, reflecting management's optimistic outlook for future performance.
- Stable Operating Cash Flow: Although operating cash flow decreased by 11.6% year-over-year to $278 million, the company anticipates maintaining approximately $1.75 billion in operating cash flow for the year, indicating strong financial stability.
See More
DIGI POWER X INC ENTERS INTO $19.6 MILLION 24-MONTH CONTRACT WITH SUBQ AI, STARTING MAY 15, 2026 - SEC FILING
Contract Details: DIGI Power X Inc. has secured a 24-month contract with SubQ, valued at approximately $19.6 million.
Effective Date: The contract is set to take effect on May 15, 2026.
See More
DIGI POWER X INC - DISCLOSES GPU RENTAL CONTRACT WITH SUBQ AI - SEC FILING
- Announcement of Agreement: DIGI POWER X INC has announced a parental agreement with SUBQ AI regarding SEC filing.
- Focus on SEC Compliance: The agreement emphasizes compliance with SEC regulations, indicating a strategic move for transparency and governance.
See More
Wall Street Earnings Season Faces Major Test
- Earnings Season Significance: Wall Street is set for a packed earnings season featuring key companies like Capital One and Boeing, with investors eager to glean insights into the economic impact of the Iran war from these reports.
- Capital One Performance Focus: Capital One is scheduled to report earnings on Tuesday, with market attention on its consumer health metrics and the progress of its acquisitions of Discover and Brex, particularly amid rising economic uncertainties.
- Boeing Earnings Outlook: Boeing is expected to release its earnings report on Wednesday, with market focus on order volumes in both its commercial and defense sectors, as well as free cash flow performance, especially after previous unexpected losses.
- GE Vernova Order Growth: GE Vernova will report alongside Boeing, with first-quarter new orders anticipated to reach $14.4 billion, reflecting a 65% year-over-year increase, indicating strong market performance amid rising electricity demand.
See More
Quest Diagnostics Set to Announce Q1 Earnings with Strong Estimates
- Earnings Announcement Date: Quest Diagnostics is set to release its Q1 earnings on April 21 before market open, with consensus EPS estimated at $2.37, reflecting a 7.2% year-over-year increase, which indicates sustained profitability and could boost investor confidence.
- Revenue Growth Expectations: The anticipated Q1 revenue of $2.83 billion represents a 6.8% year-over-year growth, highlighting strong demand in the medical testing sector and potentially laying the groundwork for future business expansion.
- Historical Performance: Over the past two years, Quest Diagnostics has beaten both EPS and revenue estimates 100% of the time, showcasing its financial robustness and market adaptability, which enhances investor confidence in its future performance.
- Estimate Revision Dynamics: In the last three months, EPS estimates have seen 5 upward revisions and 6 downward adjustments, while revenue estimates experienced 9 upward revisions with no downward changes, indicating analysts' optimistic outlook on the company's future performance, likely attracting more investor interest.
See More
Quest Diagnostics Q1 Earnings Exceed Expectations
- Earnings Beat: Quest Diagnostics reported a Q1 non-GAAP EPS of $2.50, exceeding expectations by $0.13, which reflects the company's strong performance and boosts investor confidence.
- Significant Revenue Growth: The company achieved revenues of $2.89 billion in Q1, marking a 9.1% year-over-year increase and surpassing market expectations by $60 million, indicating sustained business growth and effective market demand response.
- 2026 Guidance Update: The company raised its 2026 fiscal year net revenue guidance to between $11.78 billion and $11.90 billion, up from the previous range of $11.70 billion to $11.82 billion, reflecting an optimistic outlook for future performance.
- Stable Cash Flow: Expected operating cash flow is approximately $1.75 billion with capital expenditures around $550 million, demonstrating the company's solid financial health and investment capacity.
See More
Quest Diagnostics Reports Over 9% Revenue Growth in Q1
- Significant Revenue Growth: Quest Diagnostics reported net revenues of $2.895 billion for Q1, reflecting a 9.2% year-over-year increase, almost entirely driven by organic growth, showcasing the company's strategic execution in delivering innovative diagnostic solutions.
- Earnings Per Share Increase: The adjusted diluted EPS rose by 15.5% to $2.50, indicating successful operational efficiency and cost control, which further bolsters investor confidence in the company's financial health.
- Upgraded Full-Year Guidance: Following a robust first quarter, the company raised its 2026 revenue guidance to between $11.78 billion and $11.90 billion, with expected growth rates of 6.8% to 7.8%, reflecting management's optimistic outlook for future performance.
- Stable Operating Cash Flow: Although operating cash flow decreased by 11.6% year-over-year to $278 million, the company anticipates maintaining approximately $1.75 billion in operating cash flow for the year, indicating strong financial stability.
See More
DIGI POWER X INC ENTERS INTO $19.6 MILLION 24-MONTH CONTRACT WITH SUBQ AI, STARTING MAY 15, 2026 - SEC FILING
Contract Details: DIGI Power X Inc. has secured a 24-month contract with SubQ, valued at approximately $19.6 million.
Effective Date: The contract is set to take effect on May 15, 2026.
See More
DIGI POWER X INC - DISCLOSES GPU RENTAL CONTRACT WITH SUBQ AI - SEC FILING
- Announcement of Agreement: DIGI POWER X INC has announced a parental agreement with SUBQ AI regarding SEC filing.
- Focus on SEC Compliance: The agreement emphasizes compliance with SEC regulations, indicating a strategic move for transparency and governance.
See More
Wall Street Earnings Season Faces Major Test
- Earnings Season Significance: Wall Street is set for a packed earnings season featuring key companies like Capital One and Boeing, with investors eager to glean insights into the economic impact of the Iran war from these reports.
- Capital One Performance Focus: Capital One is scheduled to report earnings on Tuesday, with market attention on its consumer health metrics and the progress of its acquisitions of Discover and Brex, particularly amid rising economic uncertainties.
- Boeing Earnings Outlook: Boeing is expected to release its earnings report on Wednesday, with market focus on order volumes in both its commercial and defense sectors, as well as free cash flow performance, especially after previous unexpected losses.
- GE Vernova Order Growth: GE Vernova will report alongside Boeing, with first-quarter new orders anticipated to reach $14.4 billion, reflecting a 65% year-over-year increase, indicating strong market performance amid rising electricity demand.
See More
